EJNMMI Research
Scope & Guideline
Advancing the Frontiers of Nuclear Medicine and Imaging.
Introduction
Aims and Scopes
- Molecular Imaging Techniques:
The journal emphasizes innovative imaging modalities, including positron emission tomography (PET), single-photon emission computed tomography (SPECT), and hybrid imaging techniques, which are crucial for diagnosing and monitoring diseases. - Radiopharmaceutical Development:
A significant focus is on the development and validation of new radiopharmaceuticals for both diagnostic and therapeutic applications, with an aim to improve imaging accuracy and patient outcomes. - Clinical Applications and Trials:
EJNMMI Research publishes studies that explore the clinical applications of imaging technologies, including their role in oncology, neurology, cardiology, and other fields, as well as the results from clinical trials. - Quantitative Imaging and Dosimetry:
The journal covers advances in quantitative imaging methodologies and dosimetry, which are essential for optimizing treatment plans in personalized medicine. - Theranostics:
The integration of diagnostics and therapeutics, or theranostics, is a key area of research, focusing on the use of imaging to guide targeted therapies. - Artificial Intelligence and Imaging:
There is a growing interest in the application of artificial intelligence and machine learning techniques to enhance imaging analysis and interpretation, which is a significant trend within the journal.
Trending and Emerging
- Artificial Intelligence in Imaging:
The application of AI and machine learning for image reconstruction, analysis, and interpretation is rapidly gaining traction, as these technologies enhance diagnostic accuracy and efficiency. - Radiomics and Imaging Biomarkers:
The exploration of radiomics, which involves extracting a large number of features from medical images, is trending as a method for improving diagnosis and predicting treatment outcomes. - Personalized Medicine:
There is an increasing emphasis on personalized approaches in nuclear medicine, particularly in the context of cancer therapies that are tailored based on individual patient imaging and genetic profiles. - Theranostic Approaches:
The integration of diagnostic and therapeutic strategies, particularly using radioligands for targeted therapy, is emerging as a significant theme, reflecting the trend toward personalized treatment plans. - Hybrid Imaging Technologies:
The continued development and application of hybrid imaging technologies, such as PET/MRI and PET/CT, are trending, allowing for comprehensive assessments of complex diseases. - Immuno-PET Techniques:
The use of immuno-PET for evaluating immune responses and targeting specific biomarkers is gaining popularity, reflecting a broader interest in immunotherapy and its monitoring.
Declining or Waning
- Traditional Imaging Techniques:
There has been a noticeable decrease in publications focused exclusively on traditional imaging methods without the integration of newer technologies or advanced imaging analysis techniques. - Invasive Imaging Procedures:
Research papers emphasizing invasive imaging procedures are becoming less common as non-invasive techniques gain favor for their lower risk and improved patient comfort. - Basic Science Studies:
There has been a waning interest in purely basic science studies that do not translate directly to clinical applications, as the journal increasingly prioritizes translational research. - Non-targeted Imaging Agents:
The focus on non-specific or non-targeted imaging agents is decreasing, with a shift towards more personalized and targeted approaches in imaging.
Similar Journals
ANNALS OF NUCLEAR MEDICINE
Bridging Research and Practice in Nuclear MedicineANNALS OF NUCLEAR MEDICINE is a prominent academic journal dedicated to the field of nuclear medicine, published by Springer. With a rich publication history dating back to 1987 and continuing through 2024, this journal serves as a vital resource for researchers and practitioners interested in the latest developments in nuclear imaging, radiopharmaceuticals, and therapeutic applications. Ranked in the second quartile (Q2) for both Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging categories in 2023, it maintains a strong position in the academic community, with an impressive Scopus rank of #104 out of 333 in its field, placing it in the 68th percentile. The journal is not open access but offers a range of access options through institutional or individual subscriptions, ensuring that critical research findings reach a wide audience. By fostering high-quality, peer-reviewed articles, ANNALS OF NUCLEAR MEDICINE plays a crucial role in advancing the understanding and practical application of nuclear medicine techniques, making it an essential journal for professionals and students aiming to stay at the forefront of this evolving discipline.
Egyptian Journal of Radiology and Nuclear Medicine
Empowering Knowledge in Radiology and Nuclear MedicineThe Egyptian Journal of Radiology and Nuclear Medicine, published by Springer, is a premier open access journal that has provided valuable insights and advancements in the fields of radiology and nuclear medicine since its initiation in 2010. With an E-ISSN of 2090-4762, this journal is dedicated to bridging the gap between research and clinical practice, allowing for the dissemination of high-quality research to a global audience. Situated in Germany, it enjoys a robust reputation in the academic community, evidenced by its categorization in the Q3 quartile for 2023, as well as its Scopus ranking, where it holds a position of #225 out of 333 in the domain of Radiology, Nuclear Medicine and Imaging, placing it in the 32nd percentile. The journal's open access model ensures that researchers, professionals, and students can freely access innovative studies, reviews, and case reports that discuss the latest methodologies, technological advancements, and clinical outcomes in radiology and nuclear medicine. As it looks toward its converged years spanning from 2010 to 2024, the Egyptian Journal of Radiology and Nuclear Medicine continues to be an essential resource for advancing knowledge and fostering ongoing collaboration in these critical fields.
Current Cardiovascular Imaging Reports
Uncovering Insights in Cardiovascular Imaging TechnologiesCurrent Cardiovascular Imaging Reports, published by SPRINGER, is a notable academic journal within the field of cardiovascular imaging. With its ISSN 1941-9066 and E-ISSN 1941-9074, this journal has been a critical resource since its inception in 2008, aiming to disseminate high-quality research and reviews in the realm of cardiovascular diagnostics and imaging technologies. Though currently categorized within the Q3 and Q4 quartiles for various fields such as Applied Microbiology and Biotechnology, Histology, and Cell Biology, its impact and relevance are growing steadily. Researchers and practitioners can benefit from the insights presented in this journal, especially as it covers advancements and practical applications in cardiovascular imaging techniques crucial for enhancing patient care. Given its ongoing commitment to open access, although not currently available, readers can engage with significant research findings that may inform future studies and applications in cardiology. With plans to converge towards 2024, this journal is poised to facilitate the exchange of knowledge and foster innovation within its dynamic field.
PET Clinics
Enhancing Treatment Outcomes through PET Innovations.PET Clinics, published by Elsevier Inc, is a premier academic journal focusing on the advancements and applications of Positron Emission Tomography (PET) in various medical fields. With its ISSN 1556-8598 and E-ISSN 1559-7814, the journal has established a strong reputation in the scientific community, reflected in its impressive Q1 quartile rankings in Medicine (miscellaneous), Radiation, and Radiology, Nuclear Medicine, and Imaging for 2023. The journal operates within a well-defined scope that bridges innovative research and practical clinical applications, targeting professionals, researchers, and students keen on the intersection of nuclear medicine and imaging technologies. Although not an open-access journal, PET Clinics ensures accessibility through institutional subscriptions, making valuable insights available to the academic community. With an emphasis on enhancing patient care and treatment outcomes through cutting-edge imaging techniques, this journal serves as an essential resource for those seeking to expand their knowledge and expertise in the rapidly evolving field of PET.
Molecular Imaging and Radionuclide Therapy
Innovating the future of nuclear medicine and imaging.Molecular Imaging and Radionuclide Therapy is an esteemed academic journal published by GALENOS PUBL HOUSE, dedicated to advancing the fields of radiology, nuclear medicine, and imaging. Since its inception, this Open Access journal has facilitated the dissemination of high-quality research and innovative practices in molecular imaging and radionuclide therapy, making it a vital resource for researchers, professionals, and students alike. With an ISSN of 2146-1414 and an E-ISSN of 2147-1959, the journal has established its presence globally while specifically catering to the Turkish academic and medical community. As of 2023, it is ranked #241/333 in the Radiology, Nuclear Medicine and Imaging category on Scopus, holding a respectable Q3 quartile ranking. The journal serves as a platform for sharing impactful findings from 2017 to 2024, reinforcing its commitment to open access since 2011. With a dedication to enhancing the knowledge base in molecular imaging and therapy, it remains an important conduit for scholarly communication and collaborative research developments in this dynamic field.
RADIOGRAPHICS
Advancing Imaging Science for Tomorrow's HealthcareRADIOGRAPHICS, published by the Radiological Society of North America (RSNA), is a premier academic journal dedicated to the field of radiology, nuclear medicine, and imaging. With an impressive impact factor and recognition in the top quartile (Q1) of both Medicine (miscellaneous) and Radiology, Nuclear Medicine and Imaging categories, RADIOGRAPHICS stands out as a leading platform for disseminating high-quality research and clinical findings. Since its inception in 1985 and projected to run until 2024, the journal has consistently provided essential insights into cutting-edge imaging techniques and advancements in radiological practices, making it invaluable for professionals, researchers, and students alike. Although it does not offer open access, the journal continues to flourish with a robust reputation, ranked 35th in its field according to Scopus, placing it within the 89th percentile of its category. With an unwavering commitment to enhancing the understanding and application of radiological sciences, RADIOGRAPHICS remains a pivotal resource for advancing knowledge and expertise within the medical community.
Insights into Imaging
Elevating Standards in Radiology and Nuclear MedicineInsights into Imaging is a prominent open-access journal published by SPRINGER WIEN, specializing in the dynamic fields of radiology, nuclear medicine, and imaging, with its ISSN 1869-4101. Established in 2012, the journal has established itself as a leading platform for disseminating high-quality research and innovative findings, currently holding a prestigious Q1 ranking in its category as of 2023. With an impressive Scopus rank of #42 out of 333 in the medicine discipline, the journal is positioned in the 87th percentile, reflecting its significance and influence in the academic community. Based in Germany, Insights into Imaging not only provides unrestricted access to research but also aims to bridge the gap between scientific inquiry and clinical application, making it an essential resource for researchers, professionals, and students engaged in advancing imaging technologies and practices. The journal’s commitment to fostering knowledge exchange ensures that it remains a critical contributor to the evolving landscape of medical imaging, with articles available from 2012 through 2024.
NUKLEARMEDIZIN-NUCLEAR MEDICINE
Pioneering Insights in Imaging and Radiology.NUKLEARMEDIZIN-NUCLEAR MEDICINE is a prestigious journal published by Georg Thieme Verlag KG, focusing on pivotal advancements in the fields of Nuclear Medicine, Radiology, and Imaging. Established in 1959, this journal has served as a critical platform for disseminating innovative research, reviews, and clinical guidelines until its anticipated convergence in 2024. With an ISSN of 0029-5566 and an E-ISSN of 2567-6407, NUKLEARMEDIZIN is acknowledged in the academic community as a Q3 category journal within Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging as of 2023, highlighting its ongoing contribution to the interdisciplinary dialogue in healthcare. Although the journal does not currently offer open access, it remains accessible to professionals and students through various academic databases, ensuring that cutting-edge knowledge in this growing field is shared widely. Researchers interested in the latest methods and technologies in Nuclear Medicine will find NUKLEARMEDIZIN a valuable resource for enhancing their work and understanding the complexities of modern imaging modalities.
Tomography
Elevating the standards of medical imaging research.Tomography is an esteemed peer-reviewed journal published by MDPI, focusing on a broad spectrum of topics related to medical imaging and diagnostics. Launched in 2015, this Open Access journal serves as a vital platform for researchers, professionals, and students in the fields of medicine, radiology, nuclear medicine, and imaging. With an impressive impact factor reflecting its relevance, the journal has achieved a quartile ranking of Q2 in both Medicine (Miscellaneous) and Radiology, Nuclear Medicine, and Imaging as of 2023. Renowned for disseminating high-quality research, Tomography welcomes original research articles, reviews, and technical notes, fostering innovation and collaboration within the scientific community. Housed in Basel, Switzerland, the journal aims to bridge the gap between fundamental research and clinical application, appealing to a diverse readership eager to advance the field of medical imaging.
Nuclear Medicine and Molecular Imaging
Shaping the Future of Radiology through Interdisciplinary CollaborationNuclear Medicine and Molecular Imaging, published by SPRINGER HEIDELBERG, stands as a pivotal platform in the interdisciplinary field of radiology and nuclear medicine, focusing on innovative research and developments from 2010 to 2024. With its ISSN 1869-3474 and E-ISSN 1869-3482, this journal aims to disseminate advanced studies that explore the diagnostic and therapeutic applications of nuclear medicine technologies. Operating from Germany, it has positioned itself in the Q3 category within the Radiology, Nuclear Medicine and Imaging sector, showcasing its relevance among peer journals, with a Scopus rank of #204 out of 333. This journal not only serves as an essential resource for researchers and practitioners eager to stay abreast of modern methodologies and findings but also underscores the crucial advancements in molecular imaging techniques. Although currently not an open-access journal, it doesn't detract from its mission to promote knowledge exchange among academia and the medical community, thus paving the way for innovative solutions and improved patient care in nuclear medicine.